This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Archived – Unauthorized Smoking Cessation Product Resolve May Pose Health Risk
- Starting date:
- July 27, 2007
- Posting date:
- July 27, 2007
- Type of communication:
- Advisory
- Subcategory:
- Drugs
- Source of recall:
- Health Canada
- Issue:
- Unauthorized products
- Audience:
- General Public
- Identification number:
- RA-110002151
Health Canada is advising Canadians not to use the unauthorized smoking cessation product Resolve™, because of the potential health risk to consumers.
The product contains an unacceptable amount of an ingredient labelled as "Cestemenol-350." Consuming excessive amounts of this ingredient might result in damage to the kidney, liver or red blood cells.
Resolve™ is advertised as a natural stop smoking aid and is available in Cool Peppermint and Wild Cherry flavours. Resolve™ is distributed by The Winning Combination Inc. These products have been sold in retail stores across the country and are also available over the Internet.
Resolve™ is not authorized for sale in Canada. The distributor, The Winning Combination Inc., is recalling the product. Health Canada is monitoring the effectiveness of this recall.
Health Canada advises retailers to remove the product from their shelves. Consumers should return the product to the place of purchase.
Drugs and natural health products that are authorized for sale in Canada will have an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Drug Identification Number for Homeopathic Medicine (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
Consumers requiring more information about this advisory can contact Health Canada's public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.
To report a suspected adverse reaction to this product, please contact the Canadian Adverse Drug Reaction Monitoring Program (CADRMP) of Health Canada by one of the following methods:
Telephone: 1-866-234-2345
Facsimile: 1-866-678-6789
CADRMP
Marketed Health Products Directorate
Ottawa, ON, AL 0701C
K1A 0K9
email: cadrmp@hc-sc.gc.ca
The CADRMP adverse reaction reporting form, including a version that can be completed and submitted online, is located on the MedEffect area of the Health Canada Web site.
Media enquiries
Health Canada
(613) 957-2983
Public enquiries
(613) 957-2991
1-866 225-0709